Is the use of some calcium antagonists linked to cancer? Evidence from recent observational studies.
作者： Marco Pahor , Curt D. Furberg
DOI: 10.2165/00002512-199813020-00002
关键词:
摘要: In animal and in vitro studies, several calcium antagonists have been shown to block apoptosis (programmed cell death), a natural cellular defence against cancer. On the basis of these it has hypothesised that may function as cancer promoters they might cause humans.
springer.com
sci-hub.se 参考文章(39)
Lionel H. Opie, Myocardial protection by calcium antagonists Authors' publishing house : Wiley-Liss. ,(1994)
Shimon Braun, Valentina Boyko, Solomon Behar, Henrietta Reicher-Reiss, Shlomo Laniado, Elieser Kaplinsky, Uri Goldbourt, Calcium Channel Blocking Agents and Risk of Cancer in Patients With Coronary Heart Disease Journal of the American College of Cardiology. ,vol. 31, pp. 804- 808 ,(1998) , 10.1016/S0735-1097(98)00008-4
Sidhartha D. Ray, Lisa M. Kamendulis, Mark W. Gurule, Robert D. Yorkin, George B. Corcoran, Ca2+ antagonists inhibit DNA fragmentation and toxic cell death induced by acetaminophen. The FASEB Journal. ,vol. 7, pp. 453- 463 ,(1993) , 10.1096/FASEBJ.7.5.8462787
Nifedipine and cancer mortality: ten-year follow-up of 2607 patients after acute myocardial infarction. Cardiovascular Drugs and Therapy. ,vol. 12, pp. 177- 181 ,(1998) , 10.1023/A:1007731210985
Pierpaolo Correale, Pierosandro Tagliaferri, Luigi Celio, Geppino Genua, Stefania Montagnani, Angelo Raffaele Bianco, Verapamil upregulates sensitivity of human colon and breast cancer cells to LAK-cytotoxicity in vitro European Journal of Cancer and Clinical Oncology. ,vol. 27, pp. 1393- 1395 ,(1991) , 10.1016/0277-5379(91)90018-9
Marco Pahor, Jack M Guralnik, Luigi Ferrucci, Maria-Chiara Corti, Marcel E Salive, James R Cerhan, Robert B Wallace, Richard J Havlik, Calcium-channel blockade and incidence of cancer in aged populations The Lancet. ,vol. 348, pp. 493- 497 ,(1996) , 10.1016/S0140-6736(96)04277-8
L Hardell, M Fredrikson, O Axelson, Case-control study on colon cancer regarding previous diseases and drug intake. International Journal of Oncology. ,vol. 8, pp. 439- 444 ,(1996) , 10.3892/IJO.8.3.439
M Pahor, P Carbonin, J.M Guralnik, R.J Havlik, C.D Furberg, Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old The Lancet. ,vol. 347, pp. 1061- 1065 ,(1996) , 10.1016/S0140-6736(96)90276-7
M Pahor, Do Calcium Channel Blockers Increase the Risk of Cancer? American Journal of Hypertension. ,vol. 9, pp. 695- 699 ,(1996) , 10.1016/0895-7061(96)00186-0
L Juntti-Berggren, O Larsson, P Rorsman, C Ammala, K Bokvist, K Wahlander, P Nicotera, J Dypbukt, S Orrenius, A Hallberg, al. et, Increased activity of L-type Ca2+ channels exposed to serum from patients with type I diabetes Science. ,vol. 261, pp. 86- 90 ,(1993) , 10.1126/SCIENCE.7686306